NEXEON MEDSYSTEMS INC - FORM 10-K - EX-32.1 - CERTIFICATION - April 5, 2018

Attached files

file filename
EX-10.33 - CBC BANQUE AND MEDI-LINE CREDIT CONTRACT - 729-1405073-45 1.27% SECURED, 0.72% S - NEXEON MEDSYSTEMS INCf10k2017ex10-30_nexeonmed.htm
EX-31.2 - CERTIFICATION - NEXEON MEDSYSTEMS INCf10k2017ex31-2_nexeonmed.htm
EX-31.1 - CERTIFICATION - NEXEON MEDSYSTEMS INCf10k2017ex31-1_nexeonmed.htm
EX-21.1 - SUBSIDIARIES - NEXEON MEDSYSTEMS INCf10k2017ex21-1_nexeonmed.htm
EX-10.39 - WAIVER OF DEBT AGREEMENT BETWEEN NEXEON MEDSYSTEMS BELGIUM, SPRL AND NUVIANT MED - NEXEON MEDSYSTEMS INCf10k2017ex10-36_nexeonmed.htm
EX-10.38 - SHARE LOAN AGREEMENT BETWEEN MICHAEL ROSELLINI AND NEXEON MEDSYSTEMS INC DATED D - NEXEON MEDSYSTEMS INCf10k2017ex10-35_nexeonmed.htm
EX-10.37 - DEBT REPAYMENT AGREEMENT BETWEEN ROSELLINI SCIENTIFIC, LLC AND NEXEON MEDSYSTEMS - NEXEON MEDSYSTEMS INCf10k2017ex10-34_nexeonmed.htm
EX-10.36 - CBC BANQUE AND MEDI-LINE BUSINESS CREDIT LINE CREDIT CONTRACT - 729-3094852-84 D - NEXEON MEDSYSTEMS INCf10k2017ex10-33_nexeonmed.htm
EX-10.35 - KBC COMMERCIAL FINANCE INVOICE DISCOUNTING AGREEMENT DATED SEPTEMBER 29, 2017 - NEXEON MEDSYSTEMS INCf10k2017ex10-32_nexeonmed.htm
EX-10.34 - CBC BANQUE AND NEXEON MEDSYSTEMS BELGIUM, SPRL CREDIT CONTRACT - C13-66835555-84 - NEXEON MEDSYSTEMS INCf10k2017ex10-31_nexeonmed.htm
EX-10.32 - FORM SERVICES AGREEMENT BETWEEN MEDI-LINE, S.A. AND H.D. RESOURCES, S.P.R.L. DAT - NEXEON MEDSYSTEMS INCf10k2017ex10-29_nexeonmed.htm
EX-10.31 - STOCK PURCHASE AGREEMENT BETWEEN HENRI DECLOUX AND PAUL MACORS AND NEXEON MEDSYS - NEXEON MEDSYSTEMS INCf10k2017ex10-28_nexeonmed.htm
10-K - ANNUAL REPORT - NEXEON MEDSYSTEMS INCf10k2017_nexeonmedsystems.htm

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Nexeon MedSystems Inc (the “Company”) on Form 10-K for the fiscal year ended December 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officers of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company, as of, and for the periods presented in the Report.

 

Date:  April 5, 2018 /s/ William Rosellini
  William Rosellini
  Chief Executive Officer
   
  /s/ Christopher R. Miller
  Christopher R. Miller
  Chief Financial Officer

 

NEXEON MEDSYSTEMS INC Reports